124 related articles for article (PubMed ID: 9773931)
1. Importance of cytogenetic markers for multiple primary carcinomas in colorectal cancer: chromosome 17 and p53 locus translocation.
Tagawa Y; Nanashima A; Tsuji T; Sawai T; Yamaguchi H; Yasutake T; Nakagoe T; Ayabe H
J Gastroenterol; 1998 Oct; 33(5):670-7. PubMed ID: 9773931
[TBL] [Abstract][Full Text] [Related]
2. Instability of chromosome 17 and the p53 locus in non-familial colorectal cancer with multiple primary malignancies.
Sawai T; Nanashima A; Tsuji T; Yamaguchi H; Yasutake T; Nakagoe T; Ayabe H; Tagawa Y
J Exp Clin Cancer Res; 2001 Sep; 20(3):401-5. PubMed ID: 11718221
[TBL] [Abstract][Full Text] [Related]
3. Analysis of p53 gene deletions in colorectal cancers using fluorescence in situ hybridization.
Nanashima A; Tagawa Y; Yasutake T; Taniguchi Y; Sawai T; Nakagoe T; Ayabe H
Surg Today; 1997; 27(11):999-1004. PubMed ID: 9413050
[TBL] [Abstract][Full Text] [Related]
4. [Numerical aberration of chromosome 17 is correlated with multiple primary cancer in colorectal carcinoma].
Sawai T; Sasano O; Tsuji T; Nanashima A; Yasutake T; Kusano H; Tagawa Y; Nakagoe T; Ayabe H
Nihon Shokakibyo Gakkai Zasshi; 1997 Jul; 94(7):464-8. PubMed ID: 9277109
[TBL] [Abstract][Full Text] [Related]
5. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease.
Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A
Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293
[TBL] [Abstract][Full Text] [Related]
6. Deletion of chromosome 11 and development of colorectal carcinoma.
Nanashima A; Tagawa Y; Yasutake T; Fujise N; Kashima K; Nakagoe T; Ayabe H
Cancer Detect Prev; 1997; 21(1):7-11. PubMed ID: 9043757
[TBL] [Abstract][Full Text] [Related]
7. Detection of numeric abnormalities of chromosome 17 and p53 deletions by fluorescence in situ hybridization in pleomorphic adenomas and carcinomas in pleomorphic adenoma. Correlation with p53 expression.
Li X; Tsuji T; Wen S; Mimura Y; Sasaki K; Shinozaki F
Cancer; 1997 Jun; 79(12):2314-9. PubMed ID: 9191518
[TBL] [Abstract][Full Text] [Related]
8. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer].
Kashkin KN; Fleĭshman EV; Chumakov PM; Perevoshchikov AG
Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathological significance of numerical aberrations of chromosomes 11 and 17 in colorectal neoplasms.
Tagawa Y; Yasutake T; Sawai T; Nanashima A; Jibiki M; Morinaga M; Akama F; Nakagoe T; Ayabe H
Clin Cancer Res; 1997 Sep; 3(9):1587-92. PubMed ID: 9815847
[TBL] [Abstract][Full Text] [Related]
10. Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases.
Al-Mulla F; Keith WN; Pickford IR; Going JJ; Birnie GD
Genes Chromosomes Cancer; 1999 Apr; 24(4):306-14. PubMed ID: 10092128
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic aberrations detected by flow cytometry and fluorescence in situ hybridization in colorectal cancers: two cytogenetic pathways in colorectal carcinogenesis.
Sato T; Oga A; Ikeda E; Todoroki T; Furuya T; Sasaki K
Oncology; 1999 Jul; 57(1):63-9. PubMed ID: 10394127
[TBL] [Abstract][Full Text] [Related]
12. Detection of aberrations of 17p and p53 gene in gastrointestinal cancers by dual (two-color) fluorescence in situ hybridization and GeneChip p53 assay.
Takahashi Y; Nagata T; Asai S; Shintaku K; Eguchi T; Ishii Y; Fujii M; Ishikawa K
Cancer Genet Cytogenet; 2000 Aug; 121(1):38-43. PubMed ID: 10958939
[TBL] [Abstract][Full Text] [Related]
13. p53 tumor suppressor gene status and the degree of genomic instability in sporadic colorectal cancers.
Kahlenberg MS; Stoler DL; Basik M; Petrelli NJ; Rodriguez-Bigas M; Anderson GR
J Natl Cancer Inst; 1996 Nov; 88(22):1665-70. PubMed ID: 8931611
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of numerical chromosome aberrations in various morphological types of colorectal carcinomas.
Nanashima A; Tagawa Y; Morinaga M; Kusano H; Nakagoe T; Ayabe H
J Gastroenterol; 1996 Dec; 31(6):793-800. PubMed ID: 9027641
[TBL] [Abstract][Full Text] [Related]
15. Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients.
Diep CB; Thorstensen L; Meling GI; Skovlund E; Rognum TO; Lothe RA
J Clin Oncol; 2003 Mar; 21(5):820-9. PubMed ID: 12610180
[TBL] [Abstract][Full Text] [Related]
16. [Detection of chromosomal aberration using fluorescence in situ hybridization in DNA diploid colorectal carcinomas].
Jibiki M; Tagawa Y; Miyashita K; Hara S; Yasutake T; Nakazaki T; Obatake M; Sawai T; Morinaga M; Akama F
Gan To Kagaku Ryoho; 1993 Apr; 20(6):759-62. PubMed ID: 8489281
[TBL] [Abstract][Full Text] [Related]
17. Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.
Kobayashi M; Kawashima A; Mai M; Ooi A
Am J Pathol; 1996 Nov; 149(5):1575-84. PubMed ID: 8909247
[TBL] [Abstract][Full Text] [Related]
18. Numerical aberrations of chromosome 17 and the p53 locus in small hepatocellular carcinomas.
Yano H; Nanashima A; Hidaka S; Haseba M; Tanaka K; Yamaguchi H; Nakagoe T; Tagawa Y; Nagayasu T
Anticancer Res; 2004; 24(1):111-5. PubMed ID: 15015584
[TBL] [Abstract][Full Text] [Related]
19. Gene or genome? The meaning of gains/losses of chromosome.
Itoh F; Imai K
J Gastroenterol; 1999 Feb; 34(1):147-8. PubMed ID: 10204628
[No Abstract] [Full Text] [Related]
20. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
